![Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial]()
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT TrialTutt, Andrew; Tovey, Holly; Cheang, Maggie Chon U.; Kernaghan, Sarah; Kilburn, Lucy; Gazinska, Patrycja; Owen, Julie; Abraham, Jacinta; Barrett, Sophie; Barrett-Lee, Peter; Brown, Robert; Chan, Stephen; Dowsett, Mitchell; Flanagan, James M; Fox, Lisa; Grigoriadis, Anita; Gutin, Alexander; Harper-Wynne, Catherine; Hatton, Matthew Q.; Hoadley, Katherine A.; Parikh, Jyoti; Parker, Peter; Perou, Charles M.; Roylance, Rebecca; Shah, Vandna; Shaw, Adam; Smith, Ian E.; Timms, Kirsten M.; Wardley, Andrew M.; Wilson, Gregory; Gillett, Cheryl; Lanchbury, Jerry S.; Ashworth, Alan; Rahman, Nazneen; Harries, Mark; Ellis, Paul; Pinder, Sarah E.; Bliss, Judith M. · Nature Medicine · 2018